Skip to content

   Pharma Publications

Neuropsychopharmacology
  • In memoriam: Dr. Thomas Lehner
    Published on 2025-01-13
    6 months ago
  • The impact of ovulation-suppressing contraceptives on behavioral and functional difficulties in borderline personality disorder
    Published on 2025-01-10
    6 months ago
  • Multivariate patterns among multimodal neuroimaging and clinical, cognitive, and daily functioning characteristics in bipolar disorder
    Published on 2025-01-08
    6 months ago
  • Epac2 activation drives calcium permeable-AMPA receptor accumulation, fueling the incubation of cocaine craving
    Published on 2025-01-06
    6 months ago
  • The relationship between electric field strength induced by electroconvulsive therapy and cognitive and antidepressant outcomes
    Published on 2025-01-05
    6 months ago
  • Quantifying VMAT2 target occupancy at effective valbenazine doses and comparing to a novel VMAT2 inhibitor: a translational PET study
    Published on 2025-01-04
    6 months ago
  • In remembrance of Herbert Pardes, M.D. July 7, 1934–April 30, 2024
    Published on 2025-01-01
    6 months ago
« Previous 1 … 15 16 17 18 19 … 143 Next »
Journal of Psychopharmacology
  • Clinical effects of CYP2D6 phenoconversion in patients with psychosis
    Published on 2024-09-23
    10 months ago
  • Influence of panic disorder and paroxetine on brain functional hubs in drug-free patients
    Published on 2024-09-23
    10 months ago
  • Association between lifetime hallucinogen use and psychological distress varies by sexual identity in a nationally representative sample
    Published on 2024-09-23
    10 months ago
  • Ketamine for refractory depression: Save the best for last?
    Published on 2024-09-20
    10 months ago
  • Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response
    Published on 2024-09-20
    10 months ago
  • Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being
    Published on 2024-09-20
    10 months ago
  • A Phase 1 single ascending dose study of pure oral harmine in healthy volunteers
    Published on 2024-09-20
    10 months ago
« Previous 1 … 15 16 17 18 19 … 123 Next »
European Neuropsychopharmacology
  • Lung function decline in people with serious mental illness: A call to action
    Published on 2024-09-27
    9 months ago
  • Orbitofrontal cortex hypergyrification in hallucinating schizophrenia patients: Surface ratio as a promising brain biomarker
    Published on 2024-09-27
    9 months ago
  • Pioglitazone attenuates behavioral and electrophysiological dysfunctions induced by two-hit model of schizophrenia in adult rodent offspring
    Published on 2024-09-27
    9 months ago
  • Clinical research in pediatric autism
    Published on 2024-09-06
    10 months ago
  • From erectile dysfunction to dementia: A new role for sildenafil
    Published on 2024-09-06
    10 months ago
  • The myth of minimum effective dose in antipsychotic treatment for patients with remitted psychosis
    Published on 2024-09-06
    10 months ago
  • Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic research
    Published on 2024-09-06
    10 months ago
« Previous 1 … 15 16 17 18 19 … 144 Next »

   Pharma Pub